FR2723371B1 - Oligonucleotide reconnaissant une sequence d'acide nucleique a structure non lineaire, application a des fins therapeutiques et procede de preparation - Google Patents

Oligonucleotide reconnaissant une sequence d'acide nucleique a structure non lineaire, application a des fins therapeutiques et procede de preparation

Info

Publication number
FR2723371B1
FR2723371B1 FR9409578A FR9409578A FR2723371B1 FR 2723371 B1 FR2723371 B1 FR 2723371B1 FR 9409578 A FR9409578 A FR 9409578A FR 9409578 A FR9409578 A FR 9409578A FR 2723371 B1 FR2723371 B1 FR 2723371B1
Authority
FR
France
Prior art keywords
preparation
nucleic acid
acid sequence
application
therapeutic purposes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9409578A
Other languages
English (en)
Other versions
FR2723371A1 (fr
Inventor
Jean Jacques Toulme
Rakesh Mishra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR9409578A priority Critical patent/FR2723371B1/fr
Priority to PCT/FR1995/001036 priority patent/WO1996004374A1/fr
Publication of FR2723371A1 publication Critical patent/FR2723371A1/fr
Application granted granted Critical
Publication of FR2723371B1 publication Critical patent/FR2723371B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR9409578A 1994-08-02 1994-08-02 Oligonucleotide reconnaissant une sequence d'acide nucleique a structure non lineaire, application a des fins therapeutiques et procede de preparation Expired - Fee Related FR2723371B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9409578A FR2723371B1 (fr) 1994-08-02 1994-08-02 Oligonucleotide reconnaissant une sequence d'acide nucleique a structure non lineaire, application a des fins therapeutiques et procede de preparation
PCT/FR1995/001036 WO1996004374A1 (fr) 1994-08-02 1995-08-01 Oligonucleotide reconnaissant une sequence d'acide nucleique a structure non lineaire, application a des fins therapeutiques et procede de preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9409578A FR2723371B1 (fr) 1994-08-02 1994-08-02 Oligonucleotide reconnaissant une sequence d'acide nucleique a structure non lineaire, application a des fins therapeutiques et procede de preparation

Publications (2)

Publication Number Publication Date
FR2723371A1 FR2723371A1 (fr) 1996-02-09
FR2723371B1 true FR2723371B1 (fr) 1996-10-31

Family

ID=9465993

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9409578A Expired - Fee Related FR2723371B1 (fr) 1994-08-02 1994-08-02 Oligonucleotide reconnaissant une sequence d'acide nucleique a structure non lineaire, application a des fins therapeutiques et procede de preparation

Country Status (2)

Country Link
FR (1) FR2723371B1 (fr)
WO (1) WO1996004374A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101672B2 (en) 1998-05-05 2006-09-05 Third Wave Technologies, Inc. Target-dependent reactions using structure-bridging oligonucleotides
CA2289872C (fr) 1997-05-05 2007-07-31 Third Wave Technologies, Inc. Reactions dependant de la cible faisant appel a des oligonucleotides formant des ponts avec des structures
US6194149B1 (en) 1998-03-03 2001-02-27 Third Wave Technologies, Inc. Target-dependent reactions using structure-bridging oligonucleotides
US6214545B1 (en) 1997-05-05 2001-04-10 Third Wave Technologies, Inc Polymorphism analysis by nucleic acid structure probing
US6210880B1 (en) 1997-09-19 2001-04-03 Third Wave Technologies, Inc. Polymorphism analysis by nucleic acid structure probing with structure-bridging oligonucleotides
US20040092465A1 (en) * 2002-11-11 2004-05-13 Isis Pharmaceuticals Inc. Modulation of huntingtin interacting protein 1 expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9106418A (pt) * 1990-05-04 1993-05-04 Isis Pharmaceuticals Inc Processo para modular a expressao de um gene,oligonucloetideo ou analogo de oligonucleotideo e processos para tratar um animal que se suspeita tenha uma doenca e infeccao por hiv
DE69131942T2 (de) * 1990-07-16 2000-06-29 New York Health Res Inst Auswahl von effizient ziel-rns spaltenden ribozymen

Also Published As

Publication number Publication date
WO1996004374A1 (fr) 1996-02-15
FR2723371A1 (fr) 1996-02-09

Similar Documents

Publication Publication Date Title
HK1012398A1 (en) Phosphonomonoester nucleic acids, methods for their preparation and their use
DZ1759A1 (fr) Produits pharmaceutiques à base d'acide nucleique.
EP0690716A4 (fr) OLIGONUCLEOTIDES MODIFIES POUR AMELIORER LA STABILITE A pH ACIDE
FI971176A0 (fi) DNA-fotopilkkominen käyttäen teksapyriinejä
DE69503126T2 (de) Repetitive oligonukleotide matrix
HUP0004589A3 (en) Improved method for transferring nucleic acid into the striped muscle and combination therefor
AU4690596A (en) Nucleic acid condensing agents with reduced immunogenicity
FR2703053B1 (fr) Oligonucleotides agrafes et semi-agrafes, procede de preparation et applications .
GB2316411B (en) Nucleic Acid Sequencing Gels
BR9506883A (pt) Gene dna recombinante bactéria corineforme processos para produzir l-lizina e para produzir ácido l-glutâmico
FR2763852B1 (fr) Composition comprenant un derive de l'acide cinnamique et un polymere polyamine
FR2750704B1 (fr) Procede de production d'adn therapeutique
AU3216693A (en) Rna and dna molecules for producing virus resistance
EP0969714A4 (fr) Acides nucleiques de gene de resistance destines a doter des plantes d'une resistance aux maladies
FR2723371B1 (fr) Oligonucleotide reconnaissant une sequence d'acide nucleique a structure non lineaire, application a des fins therapeutiques et procede de preparation
FR2762696B1 (fr) Procede d'arret force d'imprimante
GB9408344D0 (en) Nucleic acid assays
FR2636738B1 (fr) Procede et installation de sequencage de l'adn
NO981322D0 (no) Farmasöytiske preparater for bruk ved nukleinsyretransfeksjon, og deres anvendelse
FR2760024B1 (fr) Procede de caracterisation de duplex d'acide nucleique
IT1282502B1 (it) Morsetto perfezionato, in particolare per l'aggancio a profili a sezione poligonale.
FI970696A (fi) Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi
FR2765013B1 (fr) Procede d'imbrication de balayage
FR2715404B1 (fr) Aconitases végétales et acides nucléiques codant pour ces aconitases.
HUP9901346A3 (en) Deltap62, variants thereof, nucleic acid sequences and uses thereof

Legal Events

Date Code Title Description
ST Notification of lapse